Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels
Recall from a federal regulator
Headline as published by U.S. Food and Drug Administration (Recalls) on Oct 1, 2026; collected by the wire Oct 1, 2026, 7:45 PM ET.
IMMEDIATE RELEASE - Tomball, Texas – October 1, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of its compounded glutathione to the consumer level. The product is being recalled due to potential elevated endotoxin levels.
Coverage
Topics
- Recalls and safety alertsMatched on
Recall
Explore the named firms, organizations and MDL dockets above. Sources and method